4,4-dimethyl-2,3-dihydro-1,2-benzoselenazine
-
4,4-dimethyl-2,3-dihydro-1,2-benzoselenazine
structure -
-
CAS No:
173026-17-0
-
Formula:
C10H13NSe
-
Chemical Name:
4,4-dimethyl-2,3-dihydro-1,2-benzoselenazine
-
Synonyms:
BXT 51072;BXT-51072;ALT-2074;BXT-51072;UNII-634U7OUR4R;BXT 51072;173026-17-0;634U7OUR4R;4,4-dimethyl-2,3-dihydro-1,2-benzoselenazine;SYI-2074;4,4-Dimethyl-3,4-dihydro-2H-1,2-benzoselenazine;SCHEMBL921152;CHEMBL4297259;DTXSID80169503;SYI 2074;DB05631;2H-1,2-Benzoselenazine, 3,4-dihydro-4,4-dimethyl-;Q27263560;3,4-Dihydro-4,4-dimethyl-2H-1-selena-2-azanaphthalene
-
CAS No:
Description
An organoselenium drug previously studied by Oxis International in Phase-II clinical trials for ulcerative colitis patients. Some indications of efficacy were demonstrated. BXT-51072 has enthusiastic endorsement for treatment in cardiovascular indications, primarily because of its ability to mimic the function of glutathione peroxidase.
4,4-dimethyl-2,3-dihydro-1,2-benzoselenazine Basic Attributes
226.19 g/mol
227.02132 g/mol
634U7OUR4R
DTXSID80169503
Drug Information
Investigated for use/treatment in cardiovascular disorders and diabetes mellitus type 1 and 2.
24.15 (+/-2.38) (ml min-1kg-1).
2.08 (+/-0.17) hours.
BXT 51072
Request for Quotation